These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 4377715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
    Krut LH, Seftel HC, Joffe BI.
    S Afr Med J; 1977 Mar 12; 51(11):348-52. PubMed ID: 323994
    [Abstract] [Full Text] [Related]

  • 5. Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
    Rees ED, Hamilton RD, Kanner IF, Wasson S, Hearn T.
    Atherosclerosis; 1976 Sep 12; 24(3):537-46. PubMed ID: 788722
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
    Keller C, Wolfram G, Zöllner N.
    Arzneimittelforschung; 1976 Sep 12; 26(12):2221-4. PubMed ID: 798591
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
    Jepson EM, Small E, Grayson MF, Bance G, Billimoria JD.
    Atherosclerosis; 1972 Sep 12; 16(1):9-14. PubMed ID: 4341723
    [No Abstract] [Full Text] [Related]

  • 8. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1972 Sep 12; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of several hypolipidemic agents related to clofibrate.
    Beaumont V, Buxtorf JC, Jacotot B, Beaumont JL.
    Atherosclerosis; 1974 Sep 12; 20(2):141-53. PubMed ID: 4369878
    [No Abstract] [Full Text] [Related]

  • 10. A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia.
    Rottiers R, van Egmond J.
    Acta Clin Belg; 1975 Sep 12; 30(5):398-408. PubMed ID: 1221746
    [No Abstract] [Full Text] [Related]

  • 11. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G, Keller C, Kilani C, Zöllner N.
    Verh Dtsch Ges Inn Med; 1973 Sep 12; 79():1291-3. PubMed ID: 4597609
    [No Abstract] [Full Text] [Related]

  • 12. [Familial hyperlipoproteinemia type III].
    Patsch JR, Patsch W, Sailer S, Braunsteiner H.
    Dtsch Med Wochenschr; 1976 Oct 29; 101(44):1612-9. PubMed ID: 185039
    [No Abstract] [Full Text] [Related]

  • 13. Antihyperlipidaemic agents.
    Witte EC.
    Prog Med Chem; 1975 Oct 29; 11():119-92. PubMed ID: 165566
    [No Abstract] [Full Text] [Related]

  • 14. Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
    Jain AK, Ryan JR, McMahon FG.
    N Engl J Med; 1975 Dec 18; 293(25):1283-6. PubMed ID: 171574
    [Abstract] [Full Text] [Related]

  • 15. The metabolic spectrum of halofenate.
    Ryan JR.
    Int J Clin Pharmacol Biopharm; 1975 Jul 18; 12(1-2):239-43. PubMed ID: 51838
    [Abstract] [Full Text] [Related]

  • 16. Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults.
    Bassett DR, Mikkelsen WM, Buckingham RB, Block WD, Sidiq M, Shakibai A, DiGaetano R, Liou LL.
    Clin Pharmacol Ther; 1977 Sep 18; 22(3):340-51. PubMed ID: 330079
    [No Abstract] [Full Text] [Related]

  • 17. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV, Nikul'cheva NG.
    Kardiologiia; 1976 Jul 18; 16(7):71-5. PubMed ID: 185448
    [Abstract] [Full Text] [Related]

  • 18. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Jul 18; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 19. Type IV hyperlipoproteinaemia.
    Kwiterovich PO, Margolis S.
    Clin Endocrinol Metab; 1973 Mar 18; 2(1):41-71. PubMed ID: 4359117
    [No Abstract] [Full Text] [Related]

  • 20. Effect of halofenate on serum uric acid.
    Aronow WS, Harding PR, Khursheed M, Vangrow JS, Papageorge's NP.
    Clin Pharmacol Ther; 1973 Mar 18; 14(3):371-3. PubMed ID: 4572799
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.